KotsevaKWoodDDe BacquerDet al.EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol2016; 23: 636–648.
2.
Tatulashvili S, Patois-Vergès B, Nguyen A, et al. Detection of glucose metabolism disorders in coronary patients enrolled in cardiac rehabilitation: is glycated haemoglobin useful? Data from the prospective REHABDIAB study. Eur J Prev Cardiol 2018; 25: 464–471.
3.
PiepoliMFHoesAWAgewallSet al.2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): developed with the special contribution of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR). Eur J Prev Cardiol2016; 23: NP1–NP96.
4.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care2010; 33(Suppl 1): S62–S69.
5.
KozelaMBobakMBesalaAet al.The association of depressive symptoms with cardiovascular and all-cause mortality in Central and Eastern Europe: prospective results of the HAPIEE study. Eur J Prev Cardiol2016; 23: 1839–1847.
6.
Baert A, De Smedt D, De Sutter J, et al. Factors associated with health-related quality of life in stable ambulatory congestive heart failure patients: systematic review. Eur J Prev Cardiol 2018; 25: 472–481.
7.
Totzeck M, Mincu RI, Mrotzek S, et al. Cardiovascular diseases in patients receiving small molecules with anti-vascular endothelial growth factor activity: a meta-analysis of approximately 29,000 cancer patients. Eur J Prev Cardiol 2018; 25: 482–494.
8.
NorhammarAMellbinLCosentinoF. Diabetes: prevalence, prognosis and management of a potent cardiovascular risk factor. Eur J Prev Cardiol2017; 24: 52–60.
9.
ArnoldSVInzucchiSETangFet al.Real-world use and modeled impact of glucose-lowering therapies evaluated in recent cardiovascular outcomes trials: an NCDR Research to Practice project. Eur J Prev Cardiol2017; 15: 1637–1645.
10.
Usman MS, Siddiqi TJ, Memon MM, et al. Sodium-glucose co-transporter 2 inhibitors and cardiovascular outcomes: a systematic review and meta-analysis. Eur J Prev Cardiol 2018; 25: 495–502.
11.
Pfaeffli DaleLDobsonRWhittakerRet al.The effectiveness of mobile-health behaviour change interventions for cardiovascular disease self-management: a systematic review. Eur J Prev Cardiol2016; 23: 801–817.
12.
Coorey GM, Neubeck L, Mulley J, et al. Effectiveness, acceptability and usefulness of mobile applications for cardiovascular disease self-management: systematic review with meta-synthesis of quantitative and qualitative data. Eur J Prev Cardiol 2018; 25: 505–521.
13.
CoppettiTBrauchlinAMugglerSet al.Accuracy of smartphone apps for heart rate measurement. Eur J Prev Cardiol2017; 24: 1287–1293.
14.
SaidjMJørgensenTJacobsenRKet al.Work and leisure time sitting and inactivity: effects on cardiorespiratory and metabolic health. Eur J Prev Cardiol2016; 23: 1321–1329.
15.
VasankariVHusuPVähä-YpyäHet al.Association of objectively measured sedentary behaviour and physical activity with cardiovascular disease risk. Eur J Prev Cardiol2017; 24: 1311–1318.
16.
Saeidifard F, Medina-Inojosa JR, Supervia M, et al. Differences of energy expenditure while sitting versus standing: a systematic review and meta-analysis. Eur J Prev Cardiol 2018; 25: 522–538.
17.
FerrarioMMLandsbergisPTsutsumiAet al.Work environment: an opportunity for ground-breaking collaborations in cardiovascular disease prevention. Eur J Prev Cardiol2017; 24: 4–6.
18.
Mittal TK, Cleghorn CL, Cade JE, et al. A cross-sectional survey of cardiovascular health and lifestyle habits of hospital staff in the UK: do we look after ourselves? Eur J Prev Cardiol 2018; 25: 543–550.
19.
Hansen D, Dendale P, Coninx K, et al. The European Association of Preventive Cardiology Exercise Prescription in Everyday Practice and Rehabilitative Training (EXPERT) tool: a digital training and decision support system for optimized exercise prescription in cardiovascular disease. Concept, definitions and construction methodology. Eur J Prev Cardiol 2017; 24: 1017–1031.
20.
Wald DS and Bestwick JP. Association between serum calcium, serum phosphate and aortic stenosis with implications for prevention. Eur J Prev Cardiol 2018; 25: 551–556.
21.
EichlerSSalzwedelAReibisRet al.Multicomponent cardiac rehabilitation in patients after transcatheter aortic valve implantation: predictors of functional and psychocognitive recovery. Eur J Prev Cardiol2017; 24: 257–264.
22.
RibeiroGSMeloRDDereszLFet al.Cardiac rehabilitation programme after transcatheter aortic valve implantation versus surgical aortic valve replacement: Systematic review and meta-analysis. Eur J Prev Cardiol2017; 24: 688–697.
